You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Edge to Edge (E2E)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Surgical and Percutaneous Double Orefices Mitral Repair in p2

Completed
  • Degenerative Mitral Valve Disease
  • Mitral Regurgitation
  • Central edge-to-edge
  • Milan, Italy
    IRCCS Ospedale San Raffaele - Cardiac Surgery Department
Apr 28, 2023

Transcatheter Versus Standard Surgical Mitral Valve Operation

Active, not recruiting
  • Severe Mitral Valve Regurgitation (Disorder)
  • Trancatheter Edge to Edge Repair
  • +3 more
  • Saint Denis, France
  • +1 more
Oct 14, 2021

ADHD Trial in Worldwide (Guanfacine HCl (TAK-503), Atomoxetine HCl, Placebo)

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • Guanfacine hydrochloride (TAK-503)
  • +2 more
  • Dothan, Alabama
  • +42 more
Aug 19, 2022

Deep Sedation, Mechanical Ventilation Trial in Santiago (device, behavioral, drug, procedure)

Withdrawn
  • Deep Sedation
  • Mechanical Ventilation
  • Sedation guided by SEF95 (10-13 Hz) from SedLine® monitor
  • +3 more
  • Santiago, RM, Chile
  • +1 more
Nov 2, 2022

Suture, Dermatologic Surgery, Scar Trial in Sacramento (Suture)

Completed
  • Suture
  • +3 more
  • Suture
  • Sacramento, California
    University of California, Davis
Apr 30, 2021

Cutaneous Sutures and Scar Cosmesis Trial in Sacramento (Fast absorbing gut suture)

Completed
Has Results
  • Cutaneous Sutures and Scar Cosmesis
  • Fast absorbing gut suture
  • Sacramento, California
    University of California, Davis, Department of Dermatology
Apr 20, 2021

Tricuspid Valve Regurgitation, Nonrheumatic, Cardiac Catheterization, Heart Failure, Right Sided Trial in Netherlands (TriClip

Recruiting
  • Tricuspid Valve Regurgitation, Nonrheumatic
  • +3 more
  • TriClip TTVr system (Abbott Vascular)
  • PASCAL TTVr system (Edwards Lifesciences)
  • Amsterdam, Netherlands
  • +5 more
Dec 23, 2022

ful in Assessment for ILO? A Protocol forTwo-stage Exploratory

Recruiting
  • Vocal Cord Dysfunction
  • +3 more
  • Trans-cutaneous Laryngeal ultrasound (TLUS)
  • TLUS and simultaneous laryngoscopy
  • Preston, Lancashire, United Kingdom
    Lancashire Teaching Hospitals NHS Trust
Jan 13, 2023

COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))

Completed
  • COVID-19
  • hAd5-S-Fusion+N-ETSD
  • Placebo (0.9% (w/v) saline)
  • Newport Beach, California
    Hoag Memorial Hospital Presbyterian
Sep 1, 2023

Cardiac Event, Arrest; Cardiac, Complicating Surgery, Coronary Bypass Graft Stenosis Trial in Sheffield (Bilateral Internal

Completed
  • Cardiac Event
  • +3 more
  • Bilateral Internal Mammary Artery grafts
  • Prevena
  • Sheffield, England, United Kingdom
    Sheffield Teaching Hospitals NHS FT
Mar 22, 2021

Nicotine Use Disorder Trial (E-liquid coolant (no WS-3) (1), E-liquid coolant (Low WS-3) (1), E-liquid coolant (High WS-3) (1))

Not yet recruiting
  • Nicotine Use Disorder
  • E-liquid coolant (no WS-3) (1)
  • +8 more
  • (no location specified)
Jul 7, 2023

Electronic Cigarette Use, E-Cig Use, Cigarette Smoking Trial in Los Angeles (E-cigarette e-liquid self-administration)

Completed
  • Electronic Cigarette Use
  • +3 more
  • E-cigarette e-liquid self-administration
  • Los Angeles, California
    University of Southern California
Jul 14, 2023

E-Cig Use Trial (E-liquid coolant (WS-3, 0.1%), E-liquid coolant (WS-3, 0.25%), E-liquid coolant (WS-3, 0.5%))

Not yet recruiting
  • E-Cig Use
  • E-liquid coolant (WS-3, 0.1%)
  • +9 more
  • (no location specified)
Jun 28, 2023

Vitiligo Trial in Nanjing (Exposure to white patches, Exposure to edge of white patches and normal skin around white patches)

Recruiting
  • Vitiligo
  • Exposure to white patches
  • Exposure to edge of white patches and normal skin around white patches
  • Nanjing, Jiangsu, China
    The first Affiliated hospital with Nanjing medical university
Apr 28, 2023

Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair

Recruiting
  • Mitral Regurgitation
    • New York, New York
    • +5 more
    Apr 11, 2022

    Electronic Cigarette Use, Cigarette Smoking, Cigarette Use, Electronic Trial in Los Angeles (E-cigarette)

    Completed
    • Electronic Cigarette Use
    • +3 more
    • E-cigarette
    • Los Angeles, California
      University of Southern California
    Jul 14, 2023

    Electronic Cigarettes Trial in Richmond (E-cigarette with sweetness type 1 and pronation level 1, E-cigarette with sweetness

    Not yet recruiting
    • Electronic Cigarettes
    • E-cigarette with sweetness type 1 and pronation level 1
    • +3 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Feb 2, 2023

    COVID-19, SARS-CoV-2 Infection Trial (SCTV01E-2, SCTV01E)

    Not yet recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • SCTV01E-2
    • SCTV01E
    • (no location specified)
    Jul 4, 2023

    CHoice of OptImal transCatheter trEatment for Mitral

    Recruiting
    • Mitral Regurgitation
      • Los Angeles, California
      • +25 more
      May 16, 2022

      Crohn's Disease Trial in Japan (E6011 2 mg/kg, E6011 5 mg/kg, E6011 10 mg/kg)

      Completed
      Has Results
      • Crohn's Disease
      • E6011 2 mg/kg
      • +3 more
      • Nagoya, Aichi, Japan
      • +16 more
      Apr 28, 2022

      Patient Engagement, Patient Activation, Patient Reported Outcome Measures Trial in Toronto (At-home Breast Oncology care

      Recruiting
      • Patient Engagement
      • +2 more
      • At-home Breast Oncology care Delivered with E-health solutions - ABODE
      • Toronto, Ontario, Canada
        Tulin Cil
      Aug 9, 2023

      Osteoarthrosis Trial in Seoul (E1K 1,200 ?/joint, E1K 2,400 ?/joint, )

      Recruiting
      • Osteoarthrosis
      • E1K 1,200 ㎍/joint
      • +2 more
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jan 15, 2023

      Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:

      Completed
      • COVID-19
        • Cairo, None Selected, Egypt
          balsam Sherif Fahmy
        Jul 12, 2023

        Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)

        Completed
        • Food Allergy
        • Drug: Chinese Herbal Medication
        • +2 more
        • (no location specified)
        Oct 24, 2023

        Bietti's Crystalline Dystrophy Trial in Beijing (ZVS101e)

        Recruiting
        • Bietti's Crystalline Dystrophy
        • Beijing, Beijing, China
          Peking University Third Hospital
        Feb 2, 2023